Standout Papers

Rifaximin Treatment in Hepatic Encephalopathy 2010 2026 2015 2020 826
  1. Rifaximin Treatment in Hepatic Encephalopathy (2010)
    Nathan M. Bass, Kevin D. Mullen et al. New England Journal of Medicine
  2. Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial (2021)
    Stephen A. Harrison, Peter Ruane et al. Nature Medicine
  3. Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis (2020)
    Stephen A. Harrison, Guy Neff et al. Gastroenterology
  4. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial (2023)
    Stephen A. Harrison, Rebecca Taub et al. Nature Medicine
  5. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis (2024)
    Arun J. Sanyal, Pierre Bédossa et al. New England Journal of Medicine
  6. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial (2023)
    Stephen A. Harrison, Juan P. Frías et al. ˜The œLancet. Gastroenterology & hepatology
  7. Efruxifermin in Compensated Liver Cirrhosis Caused by MASH (2025)
    Mazen Noureddin, Mary E. Rinella et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 76 standout
Sub-graph 1 of 18

Citing Papers

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
9 intermediate papers

Works of Guy Neff being referenced

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
2024
and 4 more

Author Peers

Author Last Decade Papers Cites
Guy Neff 2588 2844 1578 135 4.6k
Arie Regev 2515 2713 904 95 4.6k
Franco Filipponi 2059 1286 3144 225 5.2k
Peter T. Donaldson 5782 5049 2217 111 9.1k
Scott J. Cotler 2889 2927 719 181 4.7k
Sanjaya K. Satapathy 1669 2432 796 169 3.6k
Isabelle Colle 2996 2320 1740 157 4.8k
Elwyn Elias 4505 3559 2973 227 8.3k
John A. Goss 2038 1208 3703 223 6.1k
Peter F. Whitington 2664 2010 4941 186 8.4k
Jorge Rakela 6218 5841 2696 201 9.8k

All Works

Loading papers...

Rankless by CCL
2026